A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
/in Dendritic Cells, Glioblastoma, International PublicationsTrial watch: Dendritic cell-based anticancer immunotherapy
/in Dendritic Cells, International PublicationsPhase I Trial of Intratumoral Injection of Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 T-cell Infiltration
/in Dendritic Cells, International Publications, NSCLCSensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
/in Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenDendritic cell based vaccination strategy: an evolving paradigm
/in Dendritic Cells, Glioblastoma, International PublicationsTwelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients
/in Dendritic Cells, International Publications, Malignant MelanomaEfficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer
/in Dendritic Cells, Exosome, International Publications, Pancreatic CancerCombination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
/in Colorectal Cancer, Dendritic Cells, International PublicationsLong-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
/in Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer